CY1110620T1 - Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας - Google Patents
Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδαςInfo
- Publication number
- CY1110620T1 CY1110620T1 CY20101100378T CY101100378T CY1110620T1 CY 1110620 T1 CY1110620 T1 CY 1110620T1 CY 20101100378 T CY20101100378 T CY 20101100378T CY 101100378 T CY101100378 T CY 101100378T CY 1110620 T1 CY1110620 T1 CY 1110620T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pararrinokolpitidas
- acute
- treatment
- disease
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Αποκαλύπτονται μέθοδοι θεραπείας παραρρινοκολπίτιδας των ανώτερων αεραγωγών σε ασθενείς που προσβλήθηκαν με την εν λόγω νόσο, η οποία περιλαμβάνει χορήγηση τουλάχιστον μια φορά τη μέρα στις επιφάνειες των εν λόγων αεραγωγών των εν λόγω ασθενών μιας ποσότητας αερολυμένων σωματιδίων φουροϊκής μομεταζόνης ως μια αποτελεσματική μονοθεραπεία για τη θεραπευτική αγωγή της εν λόγω νόσου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53783004P | 2004-01-21 | 2004-01-21 | |
EP05711867A EP1711164B1 (en) | 2004-01-21 | 2005-01-19 | Method of treating acute rhinosinusitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110620T1 true CY1110620T1 (el) | 2015-04-29 |
Family
ID=34825945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100378T CY1110620T1 (el) | 2004-01-21 | 2010-04-28 | Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας |
Country Status (16)
Country | Link |
---|---|
US (2) | US20050186144A1 (el) |
EP (2) | EP2201936B1 (el) |
JP (2) | JP4976139B2 (el) |
AT (1) | ATE461693T1 (el) |
CA (1) | CA2554064A1 (el) |
CY (1) | CY1110620T1 (el) |
DE (1) | DE602005020113D1 (el) |
DK (1) | DK1711164T3 (el) |
ES (2) | ES2340777T3 (el) |
HR (1) | HRP20100208T8 (el) |
MX (1) | MXPA06008240A (el) |
PL (1) | PL1711164T3 (el) |
PT (1) | PT1711164E (el) |
RS (1) | RS51335B (el) |
SI (1) | SI1711164T1 (el) |
WO (1) | WO2005072704A2 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1711164T3 (pl) * | 2004-01-21 | 2010-09-30 | Merck Sharp & Dohme | Sposób leczenia ostrego zapalenia zatok przynosowych |
US20090325917A1 (en) * | 2006-10-19 | 2009-12-31 | Cipla Limited | Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate |
TWI411121B (zh) * | 2010-03-11 | 2013-10-01 | Ind Tech Res Inst | 光吸收層之製造方法及應用其之太陽能電池結構 |
WO2014106021A1 (en) | 2012-12-27 | 2014-07-03 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
JP7085485B2 (ja) | 2016-01-15 | 2022-06-16 | マサチューセッツ アイ アンド イヤー インファーマリー | 分泌型p-糖タンパク質は、慢性鼻副鼻腔炎の非侵襲的バイオマーカーである |
IL299210A (en) * | 2020-06-21 | 2023-02-01 | Massachusetts Eye & Ear Infirmary | Combined treatment of verapamil and methotrexate for the treatment of chronic rhinosinusitis |
JP2024049405A (ja) * | 2021-02-22 | 2024-04-10 | 興和株式会社 | 新規吸入剤 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3260474D1 (en) * | 1981-02-02 | 1984-09-06 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
US4731447A (en) | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
US4873335A (en) * | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
IL102131A0 (en) | 1991-06-10 | 1993-01-14 | Schering Corp | Non-chlorofluorocarbon aerosol formulations |
DE69231991T2 (de) * | 1991-06-10 | 2002-04-04 | Schering Corp | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen |
US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
US6068832A (en) | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
US6297227B1 (en) * | 1998-09-10 | 2001-10-02 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
US6465581B1 (en) * | 2001-01-24 | 2002-10-15 | The Goodyear Tire & Rubber Company | Silica reinforced rubber composition which contains stabilized unsymmetrical coupling agents and article of manufacture, including a tire, having at least one component comprised of such rubber composition |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
JP2005536538A (ja) * | 2002-08-23 | 2005-12-02 | シェーリング コーポレイション | 薬学的組成物 |
US20040081625A1 (en) * | 2002-10-21 | 2004-04-29 | Schering Corporation | Nasal formulations for the treatment of allergies |
US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
CN1870976A (zh) * | 2003-10-20 | 2006-11-29 | 先灵公司 | 药物组合物 |
PL1711164T3 (pl) * | 2004-01-21 | 2010-09-30 | Merck Sharp & Dohme | Sposób leczenia ostrego zapalenia zatok przynosowych |
CN103429296A (zh) | 2010-12-13 | 2013-12-04 | 内诺斯蒂姆股份有限公司 | 递送导管系统和方法 |
US9106249B1 (en) | 2014-09-04 | 2015-08-11 | Semtech Corporation | Calibration of a time-interleaved analog-to-digital converter |
-
2005
- 2005-01-19 PL PL05711867T patent/PL1711164T3/pl unknown
- 2005-01-19 ES ES05711867T patent/ES2340777T3/es active Active
- 2005-01-19 CA CA002554064A patent/CA2554064A1/en not_active Abandoned
- 2005-01-19 SI SI200531000T patent/SI1711164T1/sl unknown
- 2005-01-19 AT AT05711867T patent/ATE461693T1/de active
- 2005-01-19 EP EP10003076.6A patent/EP2201936B1/en not_active Revoked
- 2005-01-19 EP EP05711867A patent/EP1711164B1/en active Active
- 2005-01-19 US US11/038,343 patent/US20050186144A1/en not_active Abandoned
- 2005-01-19 PT PT05711867T patent/PT1711164E/pt unknown
- 2005-01-19 JP JP2006551345A patent/JP4976139B2/ja not_active Expired - Fee Related
- 2005-01-19 WO PCT/US2005/002105 patent/WO2005072704A2/en active Application Filing
- 2005-01-19 DE DE602005020113T patent/DE602005020113D1/de active Active
- 2005-01-19 RS RSP-2010/0236A patent/RS51335B/en unknown
- 2005-01-19 MX MXPA06008240A patent/MXPA06008240A/es active IP Right Grant
- 2005-01-19 DK DK05711867.1T patent/DK1711164T3/da active
- 2005-01-19 ES ES10003076T patent/ES2426957T3/es active Active
-
2008
- 2008-01-28 JP JP2008016970A patent/JP2008110991A/ja active Pending
- 2008-07-11 US US12/171,989 patent/US20090022671A1/en not_active Abandoned
-
2010
- 2010-04-13 HR HR20100208T patent/HRP20100208T8/xx unknown
- 2010-04-28 CY CY20101100378T patent/CY1110620T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP2201936A1 (en) | 2010-06-30 |
PT1711164E (pt) | 2010-06-28 |
EP2201936B1 (en) | 2013-06-19 |
PL1711164T3 (pl) | 2010-09-30 |
EP1711164B1 (en) | 2010-03-24 |
WO2005072704A2 (en) | 2005-08-11 |
US20090022671A1 (en) | 2009-01-22 |
MXPA06008240A (es) | 2006-08-31 |
SI1711164T1 (sl) | 2010-06-30 |
HRP20100208T8 (en) | 2010-06-30 |
DK1711164T3 (da) | 2010-07-19 |
CA2554064A1 (en) | 2005-08-11 |
RS51335B (en) | 2011-02-28 |
ES2426957T3 (es) | 2013-10-28 |
JP4976139B2 (ja) | 2012-07-18 |
ES2340777T3 (es) | 2010-06-09 |
HRP20100208T1 (hr) | 2010-05-31 |
JP2008110991A (ja) | 2008-05-15 |
JP2007518817A (ja) | 2007-07-12 |
DE602005020113D1 (de) | 2010-05-06 |
US20050186144A1 (en) | 2005-08-25 |
WO2005072704A3 (en) | 2006-07-20 |
ATE461693T1 (de) | 2010-04-15 |
EP1711164A2 (en) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110620T1 (el) | Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας | |
LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
WO2006078463A3 (en) | Method for treating cardiovascular disease | |
NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
HK1166465A1 (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as parp inhibitors for use in treating cancer | |
LU92232I2 (fr) | "Florbétapir (18 F)" | |
EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
WO2006085149A3 (en) | Methods and compositions for treating amyloid-related diseases | |
BRPI0418745A (pt) | anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente | |
CY1112397T1 (el) | Συνδυασμενη θεραπεια για την αντιμετωπιση του καρκινου | |
WO2006047631A3 (en) | Anti-mitotic anti-proliferative compounds | |
PT2383271E (pt) | Aminoquinolonas como inibidores de gsk-3 | |
HK1125855A1 (en) | Use of oligouronates for treating mucus hyperviscosity | |
SI2380584T1 (sl) | Imunostimulatorni postopek | |
HK1097774A1 (en) | Stable pharmaceutical composition comprising linezolid from iv | |
TW200740441A (en) | Methods and reagents for the treatment of inflammatory disorders | |
CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
WO2006078713A3 (en) | Methotrexate combinations for treating inflammatory diseases | |
BRPI0503827A (pt) | métodos para prevenir ou tratar infecções respiratórias em lactentes | |
WO2008019388A3 (en) | Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome | |
WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders | |
ATE527997T1 (de) | Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien | |
RU2007103667A (ru) | Способ лечения псориаза | |
WO2008036157A3 (en) | Prophylactic and therapeutic treatment of avian influenza infections in animals |